USPTO serial 77798327
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Research Triangle Park, NC
Research Triangle Park, NC
Research Triangle Park, NC
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Arlene D. Hanks
ARLENE D. HANKS Moore & Van Allen PLLC3015 Carrington Mill BoulevardSuite 400Morrisville, NC 27560| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Providing financial services in the pharmaceutical, biotechnology and life sciences fields, namely, providing financing to pharmaceutical, biotechnology and life sciences companies for product development and commercialization, making acquisitions of products and product rights of and investments in pharmaceutical, biotechnology and life sciences companies; capital funding services to pharmaceutical, biotechnology and life sciences companies for the development and commercialization of new products, management of product portfolios, prioritization of financial resources and achievement of financial objectives; and providing financial consultation in connection with all of the above | SECTION 8 - CANCELLED | Jan 20, 2010 |
| 041 | Educational and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the fields of health care, health management and disease management, pharmaceutical sales skills, and pharmaceutical and health products, and distributing course materials in connection therewith | SECTION 8 - CANCELLED | Jan 20, 2010 |
| 042 | Clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; product development consultation in the fields of medical products and devices; research and development services with respect to the scientific aspects of healthcare policy; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others | SECTION 8 - CANCELLED | Jan 20, 2010 |
| 044 | Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, evaluating disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medicine and pharmaceuticals | SECTION 8 - CANCELLED | Jan 20, 2010 |
| 045 | Regulatory compliance research in the development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; regulatory compliance consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory compliance audits for others to ensure the accuracy and validity of information developed in the research and testing of drugs, devices and biologics in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consulting services in the fields of regulatory affairs, manufacturing compliance and validation procedures, namely, reviewing standards and practices to assure compliance with clinical trial regulations; providing regulatory information, namely, providing information regarding the examination and approval process of pharmaceutical, biotechnical, medical and diagnostic products and methodologies by governmental regulatory bodies; providing regulatory implementation services relating to the development and validation of drugs, devices and biologics, namely, assisting others in implementing procedures that comply with regulatory requirements | SECTION 8 - CANCELLED | Jan 20, 2010 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 25, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 19, 2016 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 18, 2016 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 12, 2016 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| May 27, 2015 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| May 20, 2015 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 17, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 18, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 16, 2011 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 15, 2011 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Sep 14, 2011 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 9, 2011 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 5, 2011 | IUAF | USE AMENDMENT FILED | — |
| Aug 5, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 5, 2011 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 8, 2011 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 14, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 14, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 9, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 9, 2010 | ALIE | ASSIGNED TO LIE | — |
| Oct 28, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 28, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 28, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2010 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 26, 2010 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Oct 22, 2010 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Oct 21, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 23, 2010 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Sep 23, 2010 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| May 5, 2010 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 5, 2010 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 5, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 12, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 31, 2010 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 12, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 11, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2009 | NWAP | NEW APPLICATION ENTERED | — |